A Balanced Approach: Combining Clinical Innovation with End-to-End CDMO Services
About Us
Tetra Pharm Technologies is a Danish biopharmaceutical company founded in 2018 that specializes in the development of pharmaceutical drugs aimed at the central nervous system and the immune system to treat neurological diseases and mental health disorders.
In addition to a strong R&D pipeline with lead candidates targeting chronic pain, Alzheimer’s and obesity, Tetra Pharm Technologies offers a suite of tailored end-to-end CDMO services, including drug formulation, drug delivery, testing and validation, as well as manufacturing and market consultancy.
The two business areas complement each other seamlessly, both leveraging the company's proprietary drug delivery technology, ZYNDIKATE®. This synergy enables a balanced model, where the CDMO business generates revenue that can be reinvested into further developing the R&D pipeline.